Advances in Immunogenetics: From Genetics to Immune Responses

Dear Colleagues,

The innate and adaptive immune responses have been highly scrutinized because of their crucial theoretical and clinical relevance. One of the significant applications of these studies is developing effective vaccines that protect the receiver against challenging pathogens.

The immune response mechanisms can be analyzed at different levels:

1. the genome level: identifying and characterizing immune genes and their genomic organization
2. the expressed immune repertoires level: providing the possibility for statistical and comparative analysis on a person or multiple people. Investigating a person's immune repertoire at different time points can be particularly useful for studying the effects of a vaccine. Comparing different people's repertoires can facilitate the meta-analysis of a population's immune repertoire.
3. the immune protein's structural level: providing valuable insights for engineered antibody used in diagnostic, therapeutic, and clinical indications.

The importance of enhancing these sets of knowledge, especially in the context of controlling the coronavirus disease 2019, can hardly be overstated.

In this Special Issue entitled "Advances in Immunogenetics: From Genetics to Immune Responses," we welcome all papers, reviews, methodologies, and novel softwares that help elucidate the immunogenetics field.

Prof. Dr. Sofia Kossida
Dr. Taciana Manso
Dr. Nika Abdollahi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.